Hydroxychloroquine is an immunomodulatory drug that has been used for 60 years to treat malaria and autoimmune diseases such as systemic lupus erythematosus and inflammatory arthritis, and potential new uses and benefits continue to emerge. Toxicity concerns have been addressed with updated prescribing recommendations. This antimalarial drug is now approved to treat discoid lupus, systemic lupus erythematosus, and rheumatoid arthritis.
No takes yet. Share an insight, caveat, or question.
Shippey et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: